Robert S. Sherwin, M.D., an internationally renowned diabetes researcher and director of the Yale Center for Clinical Investigation (YCCI), has been appointed chief of endocrinology in the department of internal medicine at Yale-New Haven Hospital (YNHH) and Yale School of Medicine. The endocrinology section at YNHH provides diagnosis and therapy to people with hormonal and metabolic diseases.

Sherwin, the C.N.H. Long Professor of Medicine, has been an attending physician at YNHH since 1974, as well as a consulting physician at the VA Connecticut Healthcare System in West Haven, Conn.

In addition to his role at YCCI, Sherwin directs the medical school’s Diabetes Endocrinology Research Center, and he has served as the program director of Yale’s General Clinical Research Center.

Sherwin received his undergraduate degree from Union College in Schenectady, New York, and his M.D. from Albert Einstein College of Medicine. He did his residency at Mount Sinai Hospital and was a clinical associate at the NIH before becoming a fellow in medicine (metabolism) at Yale.

He is a former president of the American Diabetes Association (ADA) and a winner of the ADA’s Banting Medal for lifetime scientific achievement in diabetes. He has published over 300 papers in scientific journals, edited textbooks and book chapters related to diabetes, and has served on national professional committees for the past 30 years.